NAMS Menopause Certification Exam Questions With Verified Answers 2026

Median age of natural menopause 51 years Characteristic hormonal change in menopause transition Declining estrogen Reproductive stage of a 49-year-old with irregular periods and vasomotor symptoms Perimenopause Definition of postmenopause 12 consecutive months without menstruation Laboratory finding supporting menopause diagnosis in a 52-year-old woman Elevated FSH (25 IU/L) Most effective treatment for moderate-to-severe hot flashes Hormone therapy Hormone therapy regimen for postmenopausal woman with intact uterus Estrogen plus progestogen Recommended treatment for hot flashes in breast cancer survivor Paroxetine Contraindication for systemic hormone therapy Unexplained vaginal bleeding Non-hormonal medication effective for menopausal sleep disturbances Gabapentin Primary risk factor for osteoporosis in postmenopausal women Estrogen deficiency Diagnosis for a 60-year-old woman with a T-score of -2.8 on DEXA scan Osteoporosis Gabapentin Improves sleep and reduces hot flashes in menopausal women. T-score of -2.8 on DEXA scan Indicates osteoporosis. First-line medication for postmenopausal osteoporosis treatment Bisphosphonates. Recommended daily calcium intake for women aged 51-70 years 1200 mg. Medication that reduces fracture risk and breast cancer risk Raloxifene. Cardiovascular risk factor that increases significantly after menopause Coronary artery disease. Contributing factor to elevated LDL cholesterol post-menopause Estrogen decline. Common metabolic change in postmenopausal women Increased visceral fat. Most effective intervention to reduce cardiovascular risk in postmenopausal women Lifestyle modification. Best approach for a woman on HT asking about cardiovascular safety Use lowest effective dose. Most common symptom of genitourinary syndrome of menopause (GSM) Vaginal dryness. First-line treatment for vaginal atrophy in postmenopausal women Vaginal estrogen. Likely cause of dyspareunia in a 57-year-old woman Vaginal atrophy. Intervention that improves sexual function in postmenopausal women Vaginal moisturizers. Potential cause of urinary urgency in a 56-year-old woman Genitourinary syndrome of menopause. Lifestyle change that reduces menopausal hot flashes Avoiding triggers. Triggers for Hot Flashes Avoiding triggers (e.g., caffeine, spicy foods) reduces hot flash frequency. Recommended Exercise for Postmenopausal Women Weight-bearing exercise strengthens bones, reducing fracture risk. Dietary Change for Cardiovascular Health The Mediterranean diet reduces cardiovascular risk through healthy fats and fiber. Priority Advice for Smoking Woman Smoking cessation reduces cardiovascular and osteoporosis risks. Recommended Screening for Osteoporosis DEXA scan is the standard for osteoporosis screening in women 65 and older. Reproductive Stage with Heavy Menstrual Bleeding Heavy bleeding is common in late perimenopause due to anovulatory cycles. Action for Breast Tenderness on HT Breast tenderness may indicate excessive HT dose, requiring reduction. Non-Hormonal Therapy for Menopausal Mood Swings Cognitive behavioral therapy improves mood symptoms in menopause. Next Step for High FRAX Score High FRAX scores warrant bisphosphonate therapy to reduce fracture risk. Lipid Profile Change Post-Menopause Estrogen loss increases LDL, raising cardiovascular risk. Potential Treatment for Decreased Libido Testosterone therapy may improve libido in postmenopausal women. Common Cognitive Symptom During Perimenopause Memory difficulties are common due to hormonal fluctuations. Condition Increasing Fracture Risk Glucocorticoids accelerate bone loss, increasing fracture risk. Safest HT Option for DVT History Transdermal estrogen has a lower thrombotic risk than oral forms. Benefit of Vaginal Estrogen Vaginal estrogen targets GSM with minimal systemic effects. Lifestyle Factor Worsening Hot Flashes Alcohol is a known trigger for hot flashes. Diagnosis for Elevated FSH and Irregular Periods Elevated FSH and irregular periods indicate perimenopause. Contraindicated Medication for Stroke History Certain medications are contraindicated in a woman with a history of stroke. Systemic HT Contraindicated in women with a stroke history. Recommended vitamin D intake for postmenopausal women 800-1000 IU daily for bone health. Potential menopausal cause of joint pain Estrogen decline may contribute to joint pain in menopause. Intervention to reduce risk of recurrent UTIs in postmenopausal women Vaginal estrogen restores vaginal pH, reducing UTI risk. Best management for osteopenia Weight-bearing exercise is first-line for osteopenia. Factor increasing venous thromboembolism risk with oral HT Older age increases VTE risk with oral HT. Likely cause of mood swings and heavy periods Mood swings and heavy periods are typical of perimenopause. Non-hormonal treatment that improves menopausal hot flashes Clonidine, an alpha-2 agonist, reduces hot flash frequency. Common side effect of vaginal estrogen therapy Vaginal discharge is a common side effect of vaginal estrogen. Contributing factor to elevated triglycerides in postmenopausal women Estrogen loss increases triglycerides post-menopause. Lifestyle change that improves bone health in postmenopausal women Resistance training strengthens bones, reducing osteoporosis risk. Appropriate HT for women after hysterectomy Estrogen alone is sufficient for women without a uterus. Risk factor for genitourinary syndrome of menopause Low estrogen levels cause GSM symptoms. Recommended screening interval for DEXA scans in women over 65 NAMS recommends DEXA scans every 2 years for women over 65. Indicated test for fatigue and weight gain in a 52-year-old woman Fatigue and weight gain may indicate hypothyroidism, requiring TSH testing. Intervention to reduce cardiovascular risk in a 55-year-old postmenopausal woman Statins lower LDL cholesterol, reducing cardiovascular risk. Stage of a 49-year-old woman with hot flashes and normal periods Hot flashes with normal periods indicate early perimenopause. Medication used for hot flashes in women with a history of breast cancer Venlafaxine is used for hot flashes in women with a history of breast cancer. Venlafaxine An SNRI effective for hot flashes and safe in breast cancer survivors. Fall prevention strategies A non-pharmacologic intervention that reduces fracture risk in osteoporosis. Raloxifene therapy A SERM that may worsen hot flashes. Genitourinary syndrome of menopause (GSM) A likely diagnosis for vulvovaginal irritation. Caloric restriction A lifestyle change that helps manage weight gain in menopause. Systemic hormone therapy (HT) Contraindicated in women with a history of myocardial infarction. FRAX tool A test used to assess 10-year fracture risk in postmenopausal women. Night sweats A potential menopausal cause of insomnia. Regular sexual activity An intervention that improves vaginal health in postmenopausal women by increasing blood flow. T-score of -1.5 Indicates a diagnosis of osteopenia. Hypnosis A non-hormonal therapy that reduces hot flash severity. Depression screening Indicated for fatigue and mood changes. Aerobic exercise A lifestyle change that reduces cardiovascular risk in postmenopausal women. Venlafaxine (for DVT history) A safe treatment for hot flashes in women with a history of DVT. Bisphosphonate therapy Can cause esophagitis if not taken properly. Vitamin D A dietary supplement that enhances calcium absorption, supporting bone health. Irregular bleeding in perimenopause Requires endometrial evaluation to rule out malignancy. Hot flashes A common symptom experienced by women during menopause. Osteoporosis A condition characterized by weakened bones and increased fracture risk. Myocardial infarction A contraindication for systemic hormone therapy. Weight loss Not a common side effect of raloxifene therapy. Vulvovaginal irritation A hallmark symptom of genitourinary syndrome of menopause. Sedentary behavior A lifestyle factor that does not help manage menopausal weight gain. Mindfulness-based therapy Reduces anxiety in menopause. Vaginal moisturizers Safe for vaginal dryness in breast cancer survivors. Low BMI Associated with reduced bone density, increasing osteoporosis risk. Paroxetine Effective for night sweats in menopause. Lipid panel Assesses cholesterol levels, a key cardiovascular risk factor. Caffeine A common trigger for hot flashes. Denosumab A RANKL inhibitor that reduces fracture risk in osteoporosis. Low testosterone May contribute to decreased libido in menopause. Sleep hygiene practices Improve sleep quality in menopause. Vaginal lubricants Provide relief for vaginal dryness without hormones. Stress reduction Techniques decrease hot flash frequency. Zoledronic acid A bisphosphonate that treats severe osteoporosis. Endometrial biopsy Indicated to rule out malignancy in cases of irregular bleeding. Pelvic floor exercises Improve incontinence in postmenopausal women. Adequate calcium intake Reduces osteoporosis risk in postmenopausal women. Calcium intake Supports bone health, reducing osteoporosis risk. Cognitive behavioral therapy Reduces night sweats and mood swings. Blood pressure monitoring Critical for cardiovascular risk assessment. Teriparatide A parathyroid hormone analog that improves bone density in osteoporosis. Clonidine Reduces hot flash frequency in perimenopause. Perimenopause Indicated by irregular periods and vasomotor symptoms. Hormone therapy Most effective treatment for moderate-to-severe hot flashes. T-score of -2.8 Indicates osteoporosis. Bisphosphonates First-line medication for postmenopausal osteoporosis treatment. Coronary artery disease risk Increases significantly after menopause due to estrogen loss. Increased visceral fat Common metabolic change in postmenopausal women. Vaginal dryness The hallmark symptom of genitourinary syndrome of menopause (GSM). Dyspareunia Caused by vaginal atrophy in GSM. Avoiding triggers Reduces menopausal hot flash frequency. Smoking cessation Reduces multiple menopausal risks.